GNTA
Price
$4.00
Change
-$0.30 (-6.98%)
Updated
Jun 6 closing price
Capitalization
73.19M
PHIO
Price
$2.96
Change
+$0.50 (+20.33%)
Updated
Jun 6 closing price
Capitalization
14.2M
Interact to see
Advertisement

GNTA vs PHIO

Header iconGNTA vs PHIO Comparison
Open Charts GNTA vs PHIOBanner chart's image
Genenta Science SpA
Price$4.00
Change-$0.30 (-6.98%)
Volume$2.71K
Capitalization73.19M
Phio Pharmaceuticals
Price$2.96
Change+$0.50 (+20.33%)
Volume$2.07M
Capitalization14.2M
GNTA vs PHIO Comparison Chart
Loading...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNTA vs. PHIO commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNTA is a Hold and PHIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (GNTA: $4.00 vs. PHIO: $2.96)
Brand notoriety: GNTA and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNTA: 46% vs. PHIO: 47%
Market capitalization -- GNTA: $73.19M vs. PHIO: $14.2M
GNTA [@Biotechnology] is valued at $73.19M. PHIO’s [@Biotechnology] market capitalization is $14.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNTA’s FA Score shows that 0 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • GNTA’s FA Score: 0 green, 5 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, GNTA is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHIO’s TA Score shows that 4 TA indicator(s) are bullish.

  • PHIO’s TA Score: 4 bullish, 4 bearish.

Price Growth

GNTA (@Biotechnology) experienced а -11.07% price change this week, while PHIO (@Biotechnology) price change was +48.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

GNTA is expected to report earnings on Mar 28, 2025.

PHIO is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNTA($73.2M) has a higher market cap than PHIO($14.2M). PHIO YTD gains are higher at: 64.444 vs. GNTA (-8.002).
GNTAPHIOGNTA / PHIO
Capitalization73.2M14.2M515%
EBITDAN/A-7.41M-
Gain YTD-8.00264.444-12%
P/E RatioN/A0.01-
RevenueN/A0-
Total CashN/A5.39M-
Total DebtN/A0-
FUNDAMENTALS RATINGS
PHIO: Fundamental Ratings
PHIO
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PHIO
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTKB3.440.10
+2.99%
Cytek Biosciences
CHMG46.670.52
+1.13%
Chemung Financial Corp
CBOE222.60-0.15
-0.07%
Cboe Global Markets
OSCR15.42-0.23
-1.47%
Oscar Health
TOMZ1.06-0.08
-7.02%
TOMI Environmental Solutions

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with MTNB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
+20.33%
MTNB - PHIO
50%
Loosely correlated
+6.01%
TPST - PHIO
49%
Loosely correlated
+3.85%
SAGE - PHIO
42%
Loosely correlated
+1.03%
IMNN - PHIO
39%
Loosely correlated
+4.29%
SLRX - PHIO
36%
Loosely correlated
-4.12%
More